<DOC>
	<DOCNO>NCT01412463</DOCNO>
	<brief_summary>The objective study evaluate immediate long-term ( 12 month ) safety effectiveness primary stenting Protégé Everflex+ stent system treatment superficial femoral artery ( SFA ) lesion ( without involvement popliteal artery ) 40 mm 180 mm length .</brief_summary>
	<brief_title>DURABILITY+ : Prospective , Multi-center , Controlled Study With Everflex+ Stent SFA Lesions</brief_title>
	<detailed_description />
	<mesh_term>Peripheral Arterial Disease</mesh_term>
	<mesh_term>Peripheral Vascular Diseases</mesh_term>
	<mesh_term>Menthol</mesh_term>
	<criteria>General De novo , restenotic reoccluded ( PTA adjunct therapy , include stent stent graft ) lesion locate superficial femoral artery ( without popliteal involvement ) proximal point least one centimeter origin profunda femoralis suitable stenting Patient present score 2 4 follow Rutherford classification Patient willing comply specify followup evaluation specify time Patient &gt; 18 year old Patient ( legal representative ) understand nature procedure provide write informed consent , prior enrollment study Angiographic Inclusion Criteria The length target lesion minimally 40 mm maximally 180 mm , cover one stent The target lesion angiographic evidence stenosis restenosis &gt; 50 % occlusion pass standard guidewire manipulation Target vessel diameter visually estimate &gt; 3.5 mm &lt; 7.5 mm Prior enrollment , guidewire cross target lesion There angiographic evidence least onevesselrunoff foot , irrespective whether outflow reestablish mean previous endovascular intervention Patient eligible treatment Protégé Everflex+ stent system General Presence another stent stent graft target vessel place previous procedure Previous bypass surgery limb require access target lesion Patients antiplatelet therapy , anticoagulant thrombolytic drug contraindicate alternative available Patients know hypersensitivity nickeltitanium Patients uncorrected bleed disorder Female patient child bear potential use adequate contraceptive currently breastfeed Life expectancy less twelve month Use thrombectomy , artherectomy , cryoplasty , cut balloon , drugeluting balloon , embolic protection laser device procedure Any patient consider hemodynamically unstable onset procedure Patient currently participate another investigational drug device study complete entire follow period . Angiographic Exclusion Criteria Presence aortic thrombosis significant common femoral ipsilateral stenosis Patients exhibit persistent acute intraluminal thrombus propose target lesion site Perforation , dissection injury access site target vessel require additional stenting surgical intervention prior start index procedure Perforation angioplasty site evidence extravasation contrast medium Aneurysm locate level SFA and/or proximal popliteal</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2013</verification_date>
</DOC>